Astrana Health, Inc. (ASTH) Balance Sheet

The balance sheet is expanding rapidly, but the growth is heavily debt-funded, as total liabilities more than doubled from $773.9M to $1.7B. This suggests that the company is prioritizing scale over balance sheet strength, with leverage rising from 0.96 to 1.64 D/E. The trajectory indicates a shift from a conservative to a more aggressive capital structure, which may increase financial risk if growth does not translate into profitability.

The D/E ratio has nearly doubled over the period, indicating that management is comfortable using leverage to fund growth. However, with an ROE of only 4.2%, the return on this debt is modest, suggesting that the cost of capital may not be adequately covered. The increase in debt appears strategic, aimed at scaling operations, but it also raises refinancing risk if interest rates rise or cash flows falter.

The doubling of goodwill reflects the company's aggressive M&A strategy, but it also raises impairment risk if acquired businesses underperform. The minimal PPE indicates that the business does not require significant fixed assets, consistent with a services model. However, the heavy goodwill concentration means that any write-down could significantly impact equity, which is already thin relative to total assets.

The slower growth in equity relative to assets suggests that the company is relying more on debt than on retained earnings to finance its expansion. Retained earnings have grown steadily, from $258.0M to $342.4M, but this is insufficient to support the asset base. This may indicate that the company is not generating enough profit to internally fund its growth, which could be a concern for shareholders.

The current ratio has declined steadily, suggesting that current liabilities are growing faster than current assets. Although cash remains substantial, the increase in debt and the need to service it may strain liquidity. The company's ability to cover short-term obligations is weakening, which could be a concern if operating cash flows deteriorate.